web analytics
Softgel Capsule Manufacturing | Pharmaceutical Dosage Forms | Early Stage Drug Development

Softgel Capsule Manufacturing

Softgel capsules - What are the benefits to my early stage drug development project process?


Softgel capsules are a valuable pharmaceutical dosage form option for formulation of oily, oil suspended, or oil soluble compounds. Semi-solids may even be filled into softgel capsules.


Capsules are composed of either vegetable or animal derived sources and can be filled with many excipients such as oleic acid, polyethylene glycol 400 (PEG 400), and sorbitan.  These components may also aid in the bio-availability of the active pharmaceutical ingredient (API).


Early phase softgel capsule formulations can be scaled up to commercial scale.  In early phase clinical studies, hand filled softgel capsules are an extremely flexible and phase appropriate drug formulation strategy.  Fill out the form below to request your free whitepaper detailing the benefits of using hand filled softgel capsules in early phase drug development.


Hand filled softgel capsules:


             check 3 25pixelConserve limited compound supply

             check 3 25pixelMinimize excipient related side effects

             check 3 25pixelFlexible dose range




To learn more, submit the form below to receive your free whitepaper about soft gelatin capsules.


E-mail Address:



Privacy Policy

News and Events

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Read the Press Release!

Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.

View Recording!

Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.

Roundtable: M&A trends in CDMO - Molecule to Market

New Velesco Pharma clinical manufacturing facility begins operations.

Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.

Read the interview here.

Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.

Read the press release here.

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!

1 new job postings! Careers

Velesco's work published

Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.

Follow Velesco

LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter FB FindUsOnFacebook 100